OA09682A - Substituted benzimidazoles process for their preparation and their pharmaceutical use - Google Patents

Substituted benzimidazoles process for their preparation and their pharmaceutical use

Info

Publication number
OA09682A
OA09682A OA60306A OA60306A OA09682A OA 09682 A OA09682 A OA 09682A OA 60306 A OA60306 A OA 60306A OA 60306 A OA60306 A OA 60306A OA 09682 A OA09682 A OA 09682A
Authority
OA
OAPI
Prior art keywords
preparation
pharmaceutical use
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
OA60306A
Other languages
English (en)
Inventor
Arne Elof Brandstrom
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of OA09682A publication Critical patent/OA09682A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
OA60306A 1990-06-20 1992-11-27 Substituted benzimidazoles process for their preparation and their pharmaceutical use OA09682A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
OA09682A true OA09682A (en) 1993-05-15

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60306A OA09682A (en) 1990-06-20 1992-11-27 Substituted benzimidazoles process for their preparation and their pharmaceutical use

Country Status (27)

Country Link
EP (1) EP0535081A1 (lt)
JP (1) JPH05507713A (lt)
CN (1) CN1058212A (lt)
AP (1) AP215A (lt)
AU (1) AU649453B2 (lt)
BG (1) BG97200A (lt)
CA (1) CA2083714A1 (lt)
CZ (1) CZ279772B6 (lt)
FI (1) FI925766A7 (lt)
HU (1) HUT62881A (lt)
IE (1) IE912025A1 (lt)
IL (1) IL98470A0 (lt)
IS (1) IS3721A7 (lt)
LT (2) LT3952B (lt)
LV (1) LV10953A (lt)
MA (1) MA22199A1 (lt)
NO (1) NO924775L (lt)
NZ (1) NZ238546A (lt)
OA (1) OA09682A (lt)
PT (1) PT98035A (lt)
RO (1) RO110493B1 (lt)
SE (1) SE9002206D0 (lt)
TN (1) TNSN91049A1 (lt)
TW (1) TW216418B (lt)
WO (1) WO1991019711A1 (lt)
YU (1) YU104191A (lt)
ZA (2) ZA914296B (lt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
WO2001062248A1 (en) 2000-02-24 2001-08-30 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
WO2008047681A1 (en) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole compound having gastric acid secretion inhibitory activity
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
EP3512840B1 (en) * 2016-09-14 2024-03-06 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (lt) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
KR890701580A (ko) * 1987-10-30 1989-12-21 앤더스 베딘 골(骨)손실에 관련된 질병 치료용 2-피리디닐메틸(술피닐 또는 티오) 벤즈이미다졸
WO1989005299A1 (fr) * 1987-12-11 1989-06-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux derives benzoglyoxaline
EP0415990A1 (de) * 1988-05-25 1991-03-13 Byk Gulden Lomberg Chemische Fabrik GmbH Neue fluoralkoxyverbindungen

Also Published As

Publication number Publication date
TNSN91049A1 (fr) 1992-10-25
WO1991019711A1 (en) 1991-12-26
NO924775D0 (no) 1992-12-10
BG97200A (bg) 1993-12-24
JPH05507713A (ja) 1993-11-04
CA2083714A1 (en) 1991-12-21
NO924775L (no) 1992-12-10
HUT62881A (en) 1993-06-28
PT98035A (pt) 1992-03-31
FI925766A0 (fi) 1992-12-18
NZ238546A (en) 1994-03-25
AU649453B2 (en) 1994-05-26
IL98470A0 (en) 1992-07-15
ZA914296B (en) 1992-03-25
MA22199A1 (fr) 1992-04-01
LT3952B (en) 1996-05-27
CS189491A3 (en) 1992-04-15
TW216418B (lt) 1993-11-21
YU104191A (sh) 1994-01-20
AP9100285A0 (en) 1991-07-31
CZ279772B6 (cs) 1995-06-14
IE912025A1 (en) 1992-01-01
HU9204033D0 (en) 1993-03-29
AP215A (en) 1992-09-02
LT3977B (en) 1996-06-25
EP0535081A1 (en) 1993-04-07
LTIP1713A (en) 1995-08-25
LV10953A (lv) 1995-12-20
CN1058212A (zh) 1992-01-29
FI925766A7 (fi) 1992-12-18
SE9002206D0 (sv) 1990-06-20
AU8009791A (en) 1992-01-07
IS3721A7 (is) 1991-12-21
RO110493B1 (ro) 1996-01-30
ZA914297B (en) 1992-03-25
LTIP1712A (en) 1995-08-25

Similar Documents

Publication Publication Date Title
OA09682A (en) Substituted benzimidazoles process for their preparation and their pharmaceutical use
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT69712A (en) Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them
ZA929883B (en) Pharmaceutical composition and process for the preparation thereof
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
EP0463833A3 (en) Controlled release pharmaceutical preparation and process for preparing same
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
GB9116896D0 (en) 3-deoxymannosamine derivatives and process for their preparation
HUT64059A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
GB9121776D0 (en) Benzimidazole derivatives and process for preparation thereof
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
ZA911927B (en) Labdanes and process for their preparation
CS222291A3 (en) Solid pharmaceutical mixtures and process for preparing thereof
HUT66140A (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
ZA922354B (en) Pharmaceutical composition and process for the preparation thereof
GB9000241D0 (en) Pharmaceutical use
HU9301501D0 (en) Methods for producing pyrido-benzo-indole derivatives and pharmaceutical preparatives containing them
SG67903A1 (en) Benzimidazole derivatives their production and use